Live feed03:01:00·1111dPRReleasevia QuantisnowPositive Results From Pivotal Trials of exa-cel for Transfusion-Dependent Beta Thalassemia and Severe Sickle Cell Disease Presented at the 2023 Annual European Hematology Association (EHA) CongressByQuantisnow·Wall Street's wire, on your screen.CRSP· CRISPR Therapeutics AGVRTX· Vertex Pharmaceuticals IncorporatedHealth Care
